Posted in | News | Solar Energy | Green Products

Spire Semiconductor Successfully Completes Phase I of High Efficiency Concentrator Solar Cell Program

Spire Semiconductor, a wholly owned subsidiary unit of Spire, has successfully completed Phase I of its High Efficiency Concentrator Solar Cell Program with the Department of Energy’s National Renewable Energy Laboratory (NREL). The company has been notified that Phase II of this program will be authorized by the NREL. 

Spire is a global solar company providing turnkey production lines and capital equipment for the manufacture of photovoltaic modules and cells. Spire Semiconductor, under a 18-month, $3.7 million cost share subcontract, is developing a technology to manufacture 42 percent efficient, 500 sun, concentrator solar cells for concentrator photovoltaic systems in a cost effective manner.

The progress of the project has been approved by the passing of Spire Semiconductor through the NREL Stage Gate Review. The NREL Stage Gate Review also ensures that the objectives of the contract are met by the progress. These objectives include direct manufacturing cost, estimates of key performance parameters of competitive Levelized Cost of Energy, cell Mean Time Between Failure and annual manufacturing capacity potential. During Phase I, photovoltaic cell performances of more then 39 percent was achieved.

Roger G. Little, CEO and Chairman of Spire, remarked that the company is pleased to have been provided with the signal to proceed with its program. The go-ahead validates the efforts taken by the company to develop a proprietary gallium arsenide (GaAs) concentrator solar cell that has the ability to exceed anything that is commercially available at present.

Little further added that growth in the photovoltaic industry will be a continuous process in the year 2010 and beyond. A number of benefits are offered by the concentrator photovoltaic systems.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.